Hinweis-Modus ist eingeschaltet Ausschalten

EAGB.U - Emerge ARK Genomics & Biotech ETF (USD) (CA2910042084)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
ETF & Funds ceased circulation
 
(%)
CA2910042084
EAGB.U ISIN
Exchange Traded Funds (ETF)
Fondstyp
Emerge
Anbieter
-
NAV pro Aktie
29/07/2019
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOJLU
CFI
EAGB.U
Ticker
Closed
Status
Equity
Investitionsobjekt
Biotech
Sektor
Global
Geographie
No benchmark
Benchmark
0.8 %
Gesamtkostenquote
Physical
Replikationsmethode
Nein
UCITS

Letzte Daten zum
Zum Vergleichen hinzufügen

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The Emerge ARK Genomics & Biotech ETF is an actively managed ETF that seeks long-term capital appreciation by investing in a portfolio comprised primarily of global companies focused on extending and enhancing the quality of human and other life through technological and scientific developments, improvements and advancements in biotech and genomics

EAGB.U profile

The Emerge ARK Genomics & Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The Emerge fund’s base currency is CAD and the share class was registered 29.07.2019 with unique ISIN - CA2910042084. Main exchange is Cboe Canada and ticker symbol is EAGB.U. The total expense ratio is 0.8%. The Emerge ARK Genomics & Biotech ETF (USD) pays dividends 1 time(s) per year.

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.